Technical Analysis for BIO.B - Bio-Rad Laboratories, Inc. Class B

Grade Last Price % Change Price Change
grade A 222.8 0.00% 0.00
BIO.B closed unchanged on Tuesday, June 27, 2017, on 1 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Up
See historical BIO.B trend table...

Date Alert Name Type % Chg
Jun 27 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Jun 27 Upper Bollinger Band Walk Other 0.00%
Jun 27 Reversal New Highs Setup Bullish Swing Setup 0.00%
Jun 27 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Jun 27 Boomer Buy Setup Bullish Swing Setup 0.00%

Older signals for BIO.B ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network worldwide. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Is BIO.B a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 223.0
52 Week Low 137.95
Average Volume 340
200-Day Moving Average 181.7233
50-Day Moving Average 216.799
20-Day Moving Average 221.1138
10-Day Moving Average 221.51
Average True Range 0.5152
ADX 51.89
+DI 61.08
-DI: 14.13
Chandelier Exit (Long, 3 ATRs) 221.4544
Chandelier Exit (Short, 3 ATRs) 220.9956
Upper Bollinger Band 222.8017
Lower Bollinger Band 219.4259
Percent B (%b) 1.0
Bandwidth 0.015267
MACD Line 1.5913
MACD Signal Line 1.7672
MACD Histogram -0.1759